- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Paclitaxel
Catalog No. | PI0105 |
---|---|
CAS No. | 33069-62-4 |
Molecular Formula | C47H51NO14 |
Molecular Weight | 853.91 |
Purity | 98% HPLC |
Package | 25 kg/drum |
Botanical Source | Taxaceae |
Appearance | White powder |
Storage | Stored in cool and dry places, protected from direct sunlight and heat. |
Shelf Life | 2 years |
Safety Tips of Paclitaxel
Handling of paclitaxel should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Applications
Antineoplastic
Each year, more and more people are getting cancer, especially lung and liver cancer. However, there are not enough good anti-cancer drugs. Fortunately, many herbal extracts have good antineoplastic activity. A plant-based diet can help shield you from cancer because plants are rich in anti-inflammatory and antioxidant substances that help us withstand exposure to ultraviolet radiation, air pollution and other noxious substances.
Related Researches
- 1. Multicompartment micelle-structured peptide nanoparticles: A new biocompatible gene- and drug-delivery tool.
Oubotér DD, et al. J Biomed Mater Res A 2013 May 3.
- 2. CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity.
de Graan AJ, et al. Clin Cancer Res 2013 May 2.
- 3. Clinical Outcomes after Treating Acute Coronary Syndrome Patients with a Drug-Eluting Stent: Results from REWARDS-EMI (Endeavor® for Myocardial Infarction Registry).
Dvir D, et al. Cardiovasc Revasc Med 2013 May 1.
- 4. Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer.
Clavarezza M, et al. Breast 2013 Apr 30.
- 5. Chemoradiation with Paclitaxel and Carboplatin in high-risk cervical cancer patients after radical hysterectomy: a korean gynecologic oncology group study.
Lee TS, et al. Int J Radiat Oncol Biol Phys 2013 Jun 1;86(2):304-10.
- 6. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon.
Thomas SD, et al. J Vasc Surg 2013 May 1.
- 7. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D, et al. Eur J Med Chem 2013 Apr 11;64C:215-221.
- 8. Outcome of patients treated with palliative weekly Paclitaxel plus Cetuximab in recurrent head and neck cancer after failure of platinum-based therapy.
Sosa AE, et al. Eur Arch Otorhinolaryngol 2013 May 4.
- 9. A coronary pseudoaneurysm within a restenotic stent treated by implantation of a pericardium-covered stent and drug-eluting balloon.
Vaghetti M, et al. J Invasive Cardiol 2013 May;25(5):E93-5.
- 10. Evaluation of Melphalan, Oxaliplatin, and Paclitaxel in Colon, Liver, and Gastric Cancer Cell Lines in a Short-term Exposure Model of Chemosaturation Therapy by Percutaneous Hepatic Perfusion.
Uzgare RP, et al. Anticancer Res 2013 May;33(5):1989-2000.